PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 19 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,918,617 | +81.0% | 5,986 | +35.4% | 0.08% | +75.6% |
| Q1 2023 | $3,270,542 | -15.9% | 4,421 | -99.9% | 0.04% | -26.2% |
| Q4 2022 | $3,886,943 | -1.8% | 4,421,000 | -50.0% | 0.06% | +35.6% |
| Q3 2022 | $3,958,955 | +27.3% | 8,842,000 | +151.7% | 0.04% | +21.6% |
| Q1 2022 | $3,111,000 | +3.4% | 3,513,000 | +7.7% | 0.04% | +68.2% |
| Q4 2021 | $3,009,000 | +544.3% | 3,261,000 | +518.8% | 0.02% | +450.0% |
| Q3 2021 | $467,000 | -39.0% | 527,000 | -35.6% | 0.00% | -42.9% |
| Q2 2021 | $765,000 | – | 818,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cohanzick Management, LLC | 25,112,000 | $25,557,982 | 22.10% |
| Westchester Capital Management, LLC | 8,267,000 | $8,308,536 | 0.24% |
| MACQUARIE GROUP LTD | 5,359,000 | $5,386,000 | 0.01% |